Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.020975
+0.000775 (3.84%)
At close: Sep 4, 2026
Bioxytran Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.18 | 0.51 | 0.01 | 0.03 | 0.3 | 0.07 |
Cash & Short-Term Investments | 0.18 | 0.51 | 0.01 | 0.03 | 0.3 | 0.07 |
Cash Growth | 5541.98% | 9793.56% | -80.24% | -91.17% | 308.25% | 73.57% |
Other Current Assets | - | 0 | - | - | - | - |
Total Current Assets | 0.18 | 0.51 | 0.01 | 0.03 | 0.3 | 0.07 |
Long-Term Deferred Charges | 0.16 | 0.15 | 0.13 | 0.11 | 0.08 | 0.05 |
Total Assets | 0.33 | 0.66 | 0.14 | 0.14 | 0.37 | 0.12 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0 | 0.02 | 0.01 | 0 | 0 | - |
Accrued Expenses | 1.26 | 1.48 | 0.41 | 0.3 | 1.46 | 1.16 |
Short-Term Debt | 1.21 | 1.25 | 1.09 | 1.93 | 2.17 | 2.12 |
Other Current Liabilities | 2.8 | 0.5 | 0.41 | 1.01 | 0.04 | - |
Total Current Liabilities | 5.27 | 3.25 | 1.93 | 3.24 | 3.66 | 3.28 |
Total Liabilities | 5.27 | 3.25 | 1.93 | 3.24 | 3.66 | 3.28 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.11 | 0.11 | 0.09 | 0.14 | 0.12 | 0.11 |
Additional Paid-In Capital | 18.63 | 18.3 | 17 | 13.09 | 8.39 | 5.88 |
Retained Earnings | -23.73 | -21.04 | -18.92 | -15.7 | -11.22 | -8.75 |
Comprehensive Income & Other | - | - | - | 0.05 | - | - |
Total Common Equity | -4.98 | -2.63 | -1.84 | -2.42 | -2.7 | -2.76 |
Minority Interest | - | - | - | -0.68 | -0.59 | -0.4 |
Shareholders' Equity | -4.94 | -2.59 | -1.79 | -3.1 | -3.29 | -3.16 |
Total Liabilities & Equity | 0.33 | 0.66 | 0.14 | 0.14 | 0.37 | 0.12 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1.21 | 1.25 | 1.09 | 1.93 | 2.17 | 2.12 |
Net Cash (Debt) | -1.03 | -0.74 | -1.09 | -1.9 | -1.87 | -2.05 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
Filing Date Shares Outstanding | 114.7 | 113.36 | 88.88 | 166.49 | 123.5 | 110.84 |
Total Common Shares Outstanding | 114.7 | 108.15 | 86.78 | 145.64 | 123.25 | 110.84 |
Working Capital | -5.1 | -2.74 | -1.93 | -3.22 | -3.37 | -3.21 |
Book Value Per Share | -0.04 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
Tangible Book Value | -4.98 | -2.63 | -1.84 | -2.42 | -2.7 | -2.76 |
Tangible Book Value Per Share | -0.04 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |